Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
10/03/2002 | WO2002077164A2 Isolated human aminoacylase, nucleic acid molecules encoding human aminoacylase, and uses thereof |
10/03/2002 | WO2002077002A2 Synthesis of selenium-derivatized nucleosides, nucleotides, phosphoramidites, triphosphates and nucleic acids |
10/03/2002 | WO2002002585A3 Low fluorescence nylon/glass composites for microdiagnostics |
10/03/2002 | WO2001079465A3 Nucleic acids encoding polypeptides having haloperoxidase activity |
10/03/2002 | WO2001071004A3 Proteases |
10/03/2002 | WO2001019846A9 Transgenically produced fusion proteins |
10/03/2002 | WO1999047923A3 Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof |
10/03/2002 | US20020144310 Isolated polynucleotides and polypeptides relating to loci underlying resistance to soybean cyst nematode and soybean sudden death syndrome and methods employing same |
10/03/2002 | US20020144299 Nuceotide sequences coding malarial surface protein for use in the treatment and prevention of malaria |
10/03/2002 | US20020143166 Method for removing a universal linker from an oligonucleotide |
10/03/2002 | US20020142981 Gene expression profiles in liver cancer |
10/03/2002 | US20020142961 As pharmaceuticals, diagnostics, biosensors and bioreactors |
10/03/2002 | US20020142959 As drugs, diagnostics, biosensors and bioreactors |
10/03/2002 | US20020142958 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/03/2002 | US20020142448 Antibody for use in the diagnosis, treatment and prevention of bone disorders and cancer |
10/03/2002 | US20020142445 Peptides for use in the treatment of tumors and graft versus host disease |
10/03/2002 | US20020142440 Peptide for use in the diagnosis and treatment of inflammation, cancer, arteriosclerosis and degenerative disorders |
10/03/2002 | US20020142421 Isolated human aminoacylase, nucleic acid molecules encoding human aminoacylase, and uses thereof |
10/03/2002 | US20020142419 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of bone disorders and arthritis |
10/03/2002 | US20020142414 Nucleotide sequences coding polypeptide for use in the treatment of lung defects, septic shock or inflammation |
10/03/2002 | US20020142394 Exonuclease-mediated gene assembly in directed evolution |
10/03/2002 | US20020142392 Human melanocyte stimulating hormone receptor polypeptide and DNA |
10/03/2002 | US20020142378 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
10/03/2002 | US20020142376 Peptide for use in the diagnosis and treatment of nervous system disorders |
10/03/2002 | US20020142340 Generating luminescent particles; generate reaction mixture containing biopolymers and cyanine dye, conjugate cyanine dye with biopolymer, evaluate signal from conjugate |
10/03/2002 | US20020142329 Electophoretic separation and detection of preferential particles; obtain samle, incubate with luminescent particle, apply charge, monitor migration of particle |
10/03/2002 | US20020142320 Diagnosing prostate cancer in humans; obtain fluid or tissue sample from prostate gland, monitor pax gene expression, amplified expression indicates prostate cancer |
10/03/2002 | US20020142309 Nucleic acid hairpin probes and uses thereof |
10/03/2002 | US20020142307 Preferential deprotection of a 3',5'-di-O- levulinyl nucleoside; obtain 3',5'-di-O- levulinyl nucleoside, incubate with lipase, recover 3'-O-levulinyl and 5'-O-levulinyl nucleoside |
10/03/2002 | CA2441721A1 Human potassium channel |
10/03/2002 | CA2441684A1 Isolated human aminoacylase, nucleic acid molecules encoding human aminoacylase, and uses thereof |
10/03/2002 | CA2440322A1 Oligonucleotide conjugates |
10/02/2002 | EP1246114A2 Methods for genomic analysis |
10/02/2002 | EP1245678A2 Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome |
10/02/2002 | EP1244812A1 Branched compound for use in nucleic acid detection and analysis reactions |
10/02/2002 | EP1244797A1 Fusion protein delivery system and uses thereof |
10/02/2002 | EP1244795A1 Novel human proteases and polynucleotides encoding the same |
10/02/2002 | EP1244749A2 Mobility-modifying cyanine dyes |
10/02/2002 | EP1244688A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
10/02/2002 | EP1244682A1 Process for the preparation of oligomeric compounds |
10/02/2002 | EP1244681A2 Metal cluster containing nucleotides and nucleic acids, and intermediates therefor |
10/02/2002 | EP1244667A2 Cyclohexene nucleic acids |
10/02/2002 | EP1244349A2 Pyrophosphatase stress-related proteins and methods of use in plants |
10/02/2002 | EP0804448B1 Method for the purification of short nucleic acids |
10/02/2002 | EP0717750B1 Double-stranded peptide nucleic acids |
10/02/2002 | EP0691988B1 Inhibitor of stem cell proliferation and uses thereof |
10/02/2002 | DE10113265A1 Nucleic acids stabilized against exonucleases, useful for protein production in cell-free or cellular systems, contains molecules attached to bulky specific binding partners |
10/02/2002 | DE10112348A1 Nukleotidträger zur Diagnose und Therapie oraler Erkrankungen Nukleotidträger for the diagnosis and treatment of oral diseases |
10/02/2002 | CN1372000A Gene engineering body for somatostatin gene engineering subunit seedling |
10/02/2002 | CN1371995A Human peptide transport protein coding sequence, preparation method and use thereof |
10/02/2002 | CN1371917A Liver cance high-expression gene, its coded protein and use |
10/02/2002 | CN1371916A Human siali acid conjugated immunoglobulin-like agglutinant, its coding sequence and use |
10/02/2002 | CN1371915A Novel human cell endocytic regulatory protein, its coding sequence and use |
10/02/2002 | CN1371913A Novel polypeptide-human fasciclin and elongation protein 9.46 and polynucleotide for coding said polypeptide |
10/01/2002 | US6458946 Crystals of diuridine tetraphosphate or salt thereof, process for producing the crystals, and process for producing the compounds |
10/01/2002 | US6458945 Detecting variance in nucleotide sequence; mixing adenosine-cytosine-, thymidine-, or uridine triphosphate with nucleotide in presence of polymerase |
10/01/2002 | US6458941 Recovered from waste products of oligonucleotide biosynthesis |
10/01/2002 | US6458940 Genetic engineering |
10/01/2002 | US6458931 Immunoassay, immunotherapy; cancer; side effect reduction |
10/01/2002 | US6458567 Hepatitis C Virus ribozymes |
10/01/2002 | US6458542 By detecting polymorphism in nucleic acid which encodes cardiac potassium channel mink subunit polypeptide |
10/01/2002 | US6458540 Contacting nucleic acid sample with target-protecting molecule to form complex, digesting with enzymes to form at least one 5' single-stranded region, and detecting using reporter molecule; for diseases |
10/01/2002 | US6458539 Detecting peptide or protein target in sample by exposing to non-naturally occuring photoaptamer where complexes not due to watson/crick base pairing occurs, irradiating to photocrosslink complexes, then determining complexes |
10/01/2002 | US6458532 Nucleotide and amino acid sequences; screening for increased susceptibility to manic-depressive disorder |
10/01/2002 | US6458529 Assays for promoter operability in central nervous system cells |
10/01/2002 | US6458527 Using synthetic or recombinant polypeptides as gag antigen; diagnosis of human immunodeficiency virus |
10/01/2002 | US6458366 Compounds and methods for diagnosis of tuberculosis |
10/01/2002 | US6458364 Non-splicing variants of gp350/220 |
10/01/2002 | US6458349 For treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, psoriasis; for wound healing |
10/01/2002 | CA2168459C Fusion proteins containing the c-terminal of tetanus toxin linked to a heterologous protein |
10/01/2002 | CA2168010C Tag reagent and assay method |
10/01/2002 | CA2124087C Combinatorial strategies for polymer synthesis |
10/01/2002 | CA1341389C Human granulocyte colony stimulating factor |
09/30/2002 | CA2380047A1 Methods for genomic analysis |
09/26/2002 | WO2002074995A1 Method for alteration detection |
09/26/2002 | WO2002074979A2 Expression profiles and methods of use |
09/26/2002 | WO2002074969A2 Matrix attachment regions and methods for use thereof |
09/26/2002 | WO2002074959A2 Human leucine-rich repeat containing protein expressed predominately in nervous system tissues, hlrrns1 |
09/26/2002 | WO2002074911A2 Identification of gene expression alterations underlying the aging process in mammals |
09/26/2002 | WO2002074798A2 The genome of a bifidobacterium |
09/26/2002 | WO2002074788A2 TRP2 ISOFORM TRP2-6b CONTAINING HLA-A2-RESTRICTED EPITOPES |
09/26/2002 | WO2002074326A2 Urocortin-iii and uses thereof |
09/26/2002 | WO2002074045A2 Production of pancreatic islet cells and delivery of insulin |
09/26/2002 | WO2002062957A3 Ter sites and ter binding proteins |
09/26/2002 | WO2002046214A3 Immunomodulatory protein derived from the yaba monkey tumor virus |
09/26/2002 | WO2002031155A3 Gene cluster for ramoplanin biosynthesis |
09/26/2002 | WO2001083775A3 Proteases |
09/26/2002 | WO2001019484A9 Purification device and purification method |
09/26/2002 | WO2001018017A9 Methods for detecting and enumerating campylobacter jejuni in environmental samples and for identifying antibiotic-resistant strains |
09/26/2002 | US20020137921 Oligonucleotides having chiral phosphorus linkages |
09/26/2002 | US20020137920 Magnetic pigment |
09/26/2002 | US20020137909 Designated as "PRO19598" polypeptides; diagnosis and treatment of tumors |
09/26/2002 | US20020137855 Universal supports for oligonucleotide synthesis |
09/26/2002 | US20020137719 Particulate compositions for chemical synthesis |
09/26/2002 | US20020137718 Nucleozymes |
09/26/2002 | US20020137714 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
09/26/2002 | US20020137708 Antitumor agents |
09/26/2002 | US20020137695 A nucleotide, e.g., 6-(beta-D-2-Deoxyribofuranosyl)-5-hydro-methyl-8H-pyrimido(4,5 -c)(1,2)pyridazin-7-one-5'-triphosphate, incorporated into a polynuceotide or an oligomucleotide; viricides; labels |
09/26/2002 | US20020137145 Human erythropoietin gene: high level expression in stably transfected mammalian cells |
09/26/2002 | US20020137133 Receptor proteins |